Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antidiabetic bicyclic compounds

Antidiabetic bicyclic compounds

US Patent 11225471 · Granted Jan 18, 2022

Estimated economic value: $686,573,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Tetragalnac and peptide containing conjugates and methods for delivery of oligon2025
7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine r2025
9-substituted amino triazolo quinazoline derivatives as adenosine receptor antag2024
Chromane amidine monobactam compounds for the treatment of bacterial infections2024
Tricyclic heterocycle compounds useful as HIV integrase inhibitors2024
Aza-benzothiophene compounds as STING agonists2023
Substituted pyrido[4,3-b]indoles and azepino[4,5-b]indoles as inhibitors of cGAS2022
9-substituted amino triazolo quinazoline derivatives as adenosine receptor antag2022
Substituted carbapenems for the treatment of bacterial infections2021
Tetragalnac and peptide containing conjugates and methods for delivery of oligon2021